title: [Pneumonia as a result of infection with parainfluenza virus type 4 and thrombotic thrombocytopenic purpura].
authors.forename: D A
authors.initials: DA
authors.lastname: Rodríguez-Serrano
authors.forename: M
authors.initials: M
authors.lastname: Nieto-Cabrera
authors.forename: J
authors.initials: J
authors.lastname: Conesa
authors.forename: E
authors.initials: E
authors.lastname: Culebras-López
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D018270:Carcinoma, Ductal, Breast / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D003131:Combined Modality Therapy; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D017563:Lung Diseases, Interstitial / Q000209:etiology* / Q000628:therapy / Q000821:virology; D008875:Middle Aged; D009102:Multiple Organ Failure / Q000209:etiology; D029482:Parainfluenza Virus 4, Human / Q000302:isolation & purification*; D010490:Pericardial Effusion / Q000209:etiology; D010956:Plasmapheresis; D011024:Pneumonia, Viral / Q000209:etiology* / Q000628:therapy / Q000821:virology; D011183:Postoperative Complications / Q000821:virology; D011697:Purpura, Thrombotic Thrombocytopenic / Q000209:etiology* / Q000628:therapy; D019351:Rubulavirus Infections / Q000150:complications / Q000821:virology*
chemical_list: D000890:Anti-Infective Agents